Volume 12, Issue 12, Pages (September 2015)

Slides:



Advertisements
Similar presentations
Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression Janneke G.C. Peeters, Stephin.
Advertisements

Volume 8, Issue 4, Pages (April 2017)
Volume 21, Issue 3, Pages (October 2017)
Volume 153, Issue 2, Pages (April 2013)
Volume 15, Issue 3, Pages (April 2016)
Volume 17, Issue 12, Pages (December 2016)
Volume 21, Issue 13, Pages (December 2017)
Volume 42, Issue 1, Pages (January 2015)
Volume 21, Issue 12, Pages (December 2017)
Volume 11, Issue 11, Pages (June 2015)
Volume 18, Issue 10, Pages (March 2017)
Volume 16, Issue 12, Pages (September 2016)
Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells by Ellen J. Wehrens, Gerdien.
Volume 11, Issue 2, Pages (August 2012)
Volume 44, Issue 3, Pages (November 2011)
A Phase Separation Model for Transcriptional Control
Volume 7, Issue 5, Pages (June 2014)
Volume 23, Issue 7, Pages (May 2018)
Transient N-6-Methyladenosine Transcriptome Sequencing Reveals a Regulatory Role of m6A in Splicing Efficiency  Annita Louloupi, Evgenia Ntini, Thomas.
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Kobe C. Yuen, Baoshan Xu, Ian D. Krantz, Jennifer L. Gerton 
Lucas J.T. Kaaij, Robin H. van der Weide, René F. Ketting, Elzo de Wit 
Volume 45, Issue 6, Pages (December 2016)
Volume 23, Issue 4, Pages (April 2018)
Volume 25, Issue 6, Pages e4 (November 2018)
Volume 8, Issue 6, Pages (September 2014)
Understanding Tissue-Specific Gene Regulation
Adrien Le Thomas, Georgi K. Marinov, Alexei A. Aravin  Cell Reports 
Volume 17, Issue 4, Pages (October 2015)
Volume 20, Issue 6, Pages (August 2017)
Volume 16, Issue 12, Pages (September 2016)
Volume 22, Issue 3, Pages (January 2018)
Transcriptional Profiling of Quiescent Muscle Stem Cells In Vivo
TED-Seq Identifies the Dynamics of Poly(A) Length during ER Stress
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites to Alter the Breast Cancer Cell Transcriptome  Hector L. Franco, Anusha Nagari, W. Lee Kraus 
Volume 8, Issue 4, Pages (April 2017)
Volume 63, Issue 4, Pages (August 2016)
Volume 19, Issue 4, Pages (April 2014)
Volume 7, Issue 6, Pages (June 2014)
Volume 17, Issue 6, Pages (November 2016)
Volume 60, Issue 2, Pages (October 2015)
Volume 22, Issue 3, Pages (January 2018)
B. Ajekigbe, K. Cheung, Y. Xu, A. J. Skelton, A. Panagiotopoulos, J
Wei Jiang, Yuting Liu, Rui Liu, Kun Zhang, Yi Zhang  Cell Reports 
Volume 44, Issue 3, Pages (November 2011)
Volume 64, Issue 6, Pages (December 2016)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Molecular Therapy - Nucleic Acids
Volume 25, Issue 13, Pages e5 (December 2018)
Volume 14, Issue 6, Pages (June 2014)
Volume 22, Issue 3, Pages (January 2018)
Volume 13, Issue 7, Pages (November 2015)
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
Volume 14, Issue 5, Pages (February 2016)
Volume 13, Issue 1, Pages (October 2015)
Volume 11, Issue 11, Pages (June 2015)
Volume 21, Issue 3, Pages (October 2017)
Volume 14, Issue 6, Pages (June 2014)
Volume 20, Issue 13, Pages (September 2017)
Volume 9, Issue 3, Pages (November 2014)
Volume 39, Issue 3, Pages (September 2013)
Volume 1, Issue 1, Pages (July 2015)
Volume 6, Issue 4, Pages (April 2016)
Volume 56, Issue 6, Pages (December 2014)
Volume 15, Issue 12, Pages (June 2016)
Volume 20, Issue 13, Pages (September 2017)
Volume 24, Issue 8, Pages e7 (August 2018)
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor α-Bound Enhancers  Julia B. Carleton, Kristofer.
Circular RNA Transcriptomic Analysis of Primary Human Brain Microvascular Endothelial Cells Infected with Meningitic Escherichia coli  Ruicheng Yang,
BRD4 expression and genomic distribution in B-CLL.
Presentation transcript:

Volume 12, Issue 12, Pages 1986-1996 (September 2015) Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression  Janneke G.C. Peeters, Stephin J. Vervoort, Sander C. Tan, Gerdien Mijnheer, Sytze de Roock, Sebastiaan J. Vastert, Edward E.S. Nieuwenhuis, Femke van Wijk, Berent J. Prakken, Menno P. Creyghton, Paul J. Coffer, Michal Mokry, Jorg van Loosdregt  Cell Reports  Volume 12, Issue 12, Pages 1986-1996 (September 2015) DOI: 10.1016/j.celrep.2015.08.046 Copyright © 2015 The Authors Terms and Conditions

Cell Reports 2015 12, 1986-1996DOI: (10.1016/j.celrep.2015.08.046) Copyright © 2015 The Authors Terms and Conditions

Figure 1 Identification of JIA-Associated Enhancers (A, D, G, and J) MA plots of H3K27ac signal in enhancers, based on comparisons of all replicates within the depicted groups. Red dots indicate enhancers with a FDR <0.05. (B, E, and H) Selected enhancer-associated genes that are up in activated HC cells and JIA SF-derived cells, respectively. (C, F, and I) Gene ontology terms, ranked by enrichment scores. (K) Clustering analysis based on H3K27ac signal in enhancers. (L) Principle component analysis based on H3K27ac signal in enhancers. See also Figure S1, S2, and S3. Cell Reports 2015 12, 1986-1996DOI: (10.1016/j.celrep.2015.08.046) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Identification of JIA-Associated SEs (A) Normalized distribution of H3K27ac. Representative examples are depicted. (B) Venn diagram of all SEs identified in CD4+CD45RO+ T cells from HC PB (three samples) and JIA synovium (five samples) and their associated genes and gene ontology for biological processes (ranked on enrichment score) and diseases (ranked on p value). (C) Percentage of expected (based on size) and identified JIA/RA-associated SNPs located in typical enhancers and SEs of JIA patients. (D) Number of inflammatory arthritis-associated SNPs (red dot) overlapping with the regulatory regions identified in patient cells compared with 10,000 random SNP sets (gray bars). p values were calculated with binominal cumulative distribution function. See also Figure S4. Cell Reports 2015 12, 1986-1996DOI: (10.1016/j.celrep.2015.08.046) Copyright © 2015 The Authors Terms and Conditions

Figure 3 ETS1 and RUNX1 Binding Motifs Are Enriched in JIA-Associated SEs (A) Transcription factor binding motifs enriched in JIA SEs. (B and C) Gene track for ETS1 and RUNX1 displaying ChIP-seq signals for H3K27ac, ETS, RUNX1, and DNase hypersensitivity sites. Each light-green-shaded area represents an individual SE. (D) Gene tracks for PHF19 and TRAF1 showing ChIP-seq signals for H3K27ac, ETS1, RUNX1, and DNase hypersensitivity sites and JIA/RA-associated SNPs located in these gene regions. (E) Schematic model illustrating the role of ETS1 and RUNX1 in SE-driven gene expression in JIA. Cell Reports 2015 12, 1986-1996DOI: (10.1016/j.celrep.2015.08.046) Copyright © 2015 The Authors Terms and Conditions

Figure 4 BET Inhibition Preferentially Inhibits JIA-Associated Gene Expression (A) Volcano plot of genes differentially expressed between HC PB-derived and JIA patient SF-derived CD4+CD45RO+ T cells. Red dots indicate genes with a FDR <0.05. (B) Heatmap of genes significantly different in expression between HCs and JIA patients. (C) Selected genes that are up in JIA patients. (D) Gene ontology terms related to genes that are up in JIA patients. (E) Volcano plot of genes in JIA patient synovium-derived CD4+CD45RO+ T cells differentially expressed upon JQ1(+) treatment. Red dots indicate genes with a FDR <0.05. (F) Heatmap of genes significantly different in expression between JQ1(–)- and JQ1(+)-treated JIA patient cells. (G) Selected set of downregulated genes as a result of JQ1(+) treatment. (H) Gene ontology terms related to genes that were down upon JQ1(+) treatment, ranked by enrichment scores. (I) Gene set enrichment analysis for immune-related JIA SE-associated genes affected by JQ1 treatment in JIA patient-derived cells. p value was determined using the family-wise error rate procedure. (J) Overlap between genes downregulated upon JQ1(+) treatment and genes either up- or downregulated in JIA patients compared to HCs. (K) Functionally grouped network of genes upregulated in JIA compared to HC, and downregulated with JQ1(+). See also Figure S5. Cell Reports 2015 12, 1986-1996DOI: (10.1016/j.celrep.2015.08.046) Copyright © 2015 The Authors Terms and Conditions

Figure 5 CXCR4 Is Associated with JIA and Its Expression Is Inhibited by BET Inhibitors (A) Overview of cytokines and cytokine receptors up in JIA and/or down with JQ1(+). Genes associated with an enhancer with significantly different H3K27ac occupancy (pink polygon) and SE-associated genes (green star) are depicted. (B) RNA sequencing gene track for CXCR4 for HC or JIA patient-derived CD4+ Tmem/eff cells treated with JQ1(–) or JQ1(+). (C and D) Relative RNA expression of CXCR4 in CD4+ Tmem/eff cells treated with JQ1(–) or JQ1(+); data were obtained by RNA sequencing (C) or qPCR (D). (E) Mean fluorescent intensity of CXCR4 in CD4+ Tmem/eff cells treated with JQ1(–) or JQ1(+). (F) Gene track for CXCR4 displaying ChIP-seq signals for H3K27Ac, ETS1, RUNX1, and DNase hypersensitivity sites. SNP in CXCR4-associated SE is indicated. (G) Concentration (pg/ml) SDF-1 in the PB serum and SF of JIA patients. p values were determined using an unpaired or paired Student’s t test. Cell Reports 2015 12, 1986-1996DOI: (10.1016/j.celrep.2015.08.046) Copyright © 2015 The Authors Terms and Conditions